m progression. Arterioscler Thromb Vasc Biol 2009;29:1452-7.
235. Kitagawa T, Kosuge H, Chang E, James ML, Yamamoto T,
Shen B, et al. Integrin-targeted molecular imaging of
experimental abdominal aortic aneurysms by 18F-labeled
Arg-Gly-Asp positron-emission tomography. Circ Cardiovasc Imaging 2013;6:950-6.
236. Kitagawa T, Kosuge H, Uchida M, Dua MM, Iida Y,
Dalman RL, et al. RGD-conjugated human ferritin nanoparticles for imaging vascular inﬂammation and angiogenesis in experimental carotid and aortic disease. Mol
Imaging Biol 2012;14:315-24.
237. Golestani R, Razavian M, Nie L, Zhang J, Jung JJ, Ye Y, et al.
Imaging vessel wall biology to predict outcome in
abdominal aortic aneurysm. Circ Cardiovasc Imaging
2015;8:e002471.
238. Nguyen VL, Backes WH, Kooi ME, Wishaupt MC,
Hellenthal FA, Bosboom EM, et al. Quantiﬁcation of
abdominal aortic aneurysm wall enhancement with

Journal of Vascular Surgery

Chaikof et al

61

Volume 67, Number 1
dynamic contrast-enhanced MRI: feasibility, reproducibility,
and initial experience. J Magn Reson Imaging 2014;39:
1449-56.
239. Feringa HH, Bax JJ, Boersma E, Kertai MD, Meij SH, Galal W,
et al. High-dose beta-blockers and tight heart rate control
reduce myocardial ischemia and troponin T release in
vascular surgery patients. Circulation 2006;114(Suppl):I344-9.
240. Buijs RV, Willems TP, Tio RA, Boersma HH, Tielliu IF,
Slart RH, et al.